Moderna公司周一盘前股价大涨5.08%,引发市场广泛关注。这与该公司从美国政府获得5.9亿美元资金支持密切相关,这笔资金将用于加快其禽流感疫苗mRNA-1018的开发进度。
据悉,Moderna公司将根据研究初步数据,把这款实验性注射剂推进到后期临床试验阶段,并计划在医学会议上展示相关数据。此前,该公司曾因呼吸道合胞病毒(RSV)疫苗上市缓慢、新冠疫苗需求下降等因素,下调了2025年销售预期,股价受到一定冲击。
这笔政府资助无疑为Moderna公司新药研发注入新动力,也令市场看好了公司在医疗健康领域的长期发展前景。上周五,Moderna股价年内已下跌三分之二。但在政府大力支持下,公司重振雄风的希望再次被点燃。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.